K833077 is an FDA 510(k) clearance for the WELLCOGEN H. INFLUENZAL ZL21. Classified as Antiserum, Hai, Mumps Virus (product code GRD), Class I - General Controls.
Submitted by Wellcome Diagnostics (Mchenry, US). The FDA issued a Cleared decision on January 10, 1984 after a review of 123 days - within the typical 510(k) review window.
This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.3380 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.
View all Wellcome Diagnostics devices